Transine Therapeutics Announces Final Closing of its Seed Round at £13.7m to Accelerate its Platform and Portfolio Development
May 31, 2022
Company adds £4.6m additional seed funding Strengthens investor syndicate with Epidarex joining as a new investor Enhances ability to leverage unique SINEUP® platform and rapidly